Dana-Farber Beth Israel Deaconess Cancer Collaboration
Advancing the Future of Cancer Care
Beth Israel Deaconess Medical Center (BIDMC) and its affiliated physician group, Harvard Medical Faculty Physicians (HMFP), announced in September 2023 plans to collaborate with Dana-Farber Cancer Institute (Dana-Farber) to advance the future of cancer care and build the region’s only free-standing inpatient hospital for adult cancer patients.
About Our Collaboration
The Dana-Farber Beth Israel Deaconess Cancer Collaboration will include all aspects of adult cancer care, building on each organization's legacy of excellence with compassion, innovative research, and world-class patient care.
Every day, our clinicians and researchers are working to discover new ways to prevent, treat and cure cancer. We can harness the power of these ground-breaking innovations in a state-of-the-art clinical building that is designed specifically to meet the complex needs of patients with cancer and their loved ones. In addition, the proximity of the new hospital in the Longwood Medical Area of Boston, adjacent to existing BIDMC and Dana-Farber facilities, will support a cohesive, patient-centered experience and emphasis on leading-edge research.
Together, we are creating a model that is unique in this region. We anticipate that patients and their families will benefit from a forward-looking model that will expand equitable access to life-changing cancer care, harness the power of scientific discovery and innovation and address longstanding disparities in health by collaborating on all aspects of cancer care and creating a new freestanding adult cancer hospital.
About the Proposed Inpatient Cancer Hospital
The Dana-Farber Beth Israel Deaconess Cancer Collaboration includes plans to build a freestanding, dedicated adult inpatient hospital. The proposed state-of-the-art hospital will operate under the license of Dana-Farber and provide adult medical oncology care. Together, Dana-Farber and BIDMC, with its affiliated physician group, Harvard Medical Faculty Physicians (HMFP), will establish a coordinated clinical and organizational structure for oncology care in the Longwood Medical Area of Boston.
In addition to expanding bed capacity to ensure timely access to care, the proposed new hospital will be:
- Designed specifically for the needs of patients with cancer and their loved ones;
- Flexible to adapt to new and changing technology and innovations in care; and
- Supported by the Dana-Farber, BIDMC and HMFP teams.
Timeline and What To Expect
Bringing our shared vision to life will take time, hard work and dedication. It will be several years before these changes and a new hospital are in place. In the meantime, our patients and their families, our employees and our community can be confident that we will continue to provide the excellent care we provide today uninterrupted. There will be no change in any patient care at this time, and we do not anticipate any changes for several years.
Read more about the Dana-Farber Beth Israel Deaconess Cancer Collaboration.
Read more about BIDMC’s Cancer Center and Programs.